These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
404 related items for PubMed ID: 22487948
1. Effects of combined endothelin A receptor and renin-angiotensin system blockade on the course of end-organ damage in 5/6 nephrectomized Ren-2 hypertensive rats. Vaněčková I, Kujal P, Husková Z, Vaňourková Z, Vernerová Z, Certíková Chábová V, Skaroupková P, Kramer HJ, Tesař V, Červenka L. Kidney Blood Press Res; 2012; 35(5):382-92. PubMed ID: 22487948 [Abstract] [Full Text] [Related]
2. Renin-angiotensin system blockade alone or combined with ETA receptor blockade: effects on the course of chronic kidney disease in 5/6 nephrectomized Ren-2 transgenic hypertensive rats. Sedláková L, Čertíková Chábová V, Doleželová Š, Škaroupková P, Kopkan L, Husková Z, Červenková L, Kikerlová S, Vaněčková I, Sadowski J, Kompanowska-Jezierska E, Kujal P, Kramer HJ, Červenka L. Clin Exp Hypertens; 2017; 39(2):183-195. PubMed ID: 28287881 [Abstract] [Full Text] [Related]
3. Similar renoprotection after renin-angiotensin-dependent and -independent antihypertensive therapy in 5/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects? Kujal P, Chábová VČ, Vernerová Z, Walkowska A, Kompanowska-Jezierska E, Sadowski J, Vaňourková Z, Husková Z, Opočenský M, Skaroupková P, Schejbalová S, Kramer HJ, Rakušan D, Malý J, Netuka I, Vaněčková I, Kopkan L, Cervenka L. Clin Exp Pharmacol Physiol; 2010 Dec; 37(12):1159-69. PubMed ID: 20880190 [Abstract] [Full Text] [Related]
4. Addition of ET(A) receptor blockade increases renoprotection provided by renin-angiotensin system blockade in 5/6 nephrectomized Ren-2 transgenic rats. Čertíková Chábová V, Vernerová Z, Kujal P, Husková Z, Škaroupková P, Tesař V, Kramer HJ, Kompanowska-Jezierska E, Walkowska A, Sadowski J, Červenka L, Vaněčková I. Life Sci; 2014 Nov 24; 118(2):297-305. PubMed ID: 24373834 [Abstract] [Full Text] [Related]
5. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin. Lebel M, Rodrigue ME, Agharazii M, Larivière R. Am J Hypertens; 2006 Dec 24; 19(12):1286-92. PubMed ID: 17161776 [Abstract] [Full Text] [Related]
6. Effects of combined endothelin and angiotensin II antagonism on growth factor-induced proliferation of vascular smooth muscle cells isolated from uremic rats. Wolf SC, Sauter G, Risler T, Brehm BR. Ren Fail; 2005 Dec 24; 27(4):465-74. PubMed ID: 16060137 [Abstract] [Full Text] [Related]
7. Moderate additive effects of endothelin receptor A blockade in Ren-2 transgenic rats subjected to various types of RAS blockade. Vaněčková I, Řezáčová L, Kuneš J, Zicha J. Life Sci; 2016 Aug 15; 159():127-134. PubMed ID: 26775568 [Abstract] [Full Text] [Related]
8. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better? Weir MR. Clin Ther; 2007 Sep 15; 29(9):1803-24. PubMed ID: 18035185 [Abstract] [Full Text] [Related]
9. Blockade of endothelin receptors attenuates end-organ damage in homozygous hypertensive ren-2 transgenic rats. Dvorák P, Kramer HJ, Bäcker A, Malý J, Kopkan L, Vanecková I, Vernerová Z, Opocenský M, Tesar V, Bader M, Ganten D, Janda J, Cervenka L. Kidney Blood Press Res; 2004 Sep 15; 27(4):248-58. PubMed ID: 15286437 [Abstract] [Full Text] [Related]
10. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat. Erman A, Veksler S, Gafter U, Boner G, Wittenberg C, van Dijk DJ. J Renin Angiotensin Aldosterone Syst; 2004 Sep 15; 5(3):146-51. PubMed ID: 15526251 [Abstract] [Full Text] [Related]
12. Combined Inhibition of Soluble Epoxide Hydrolase and Renin-Angiotensin System Exhibits Superior Renoprotection to Renin-Angiotensin System Blockade in 5/6 Nephrectomized Ren-2 Transgenic Hypertensive Rats with Established Chronic Kidney Disease. Čertíková Chábová V, Kujal P, Škaroupková P, Varňourková Z, Vacková Š, Husková Z, Kikerlová S, Sadowski J, Kompanowska-Jezierska E, Baranowska I, Hwang SH, Hammock BD, Imig JD, Tesař V, Červenka L. Kidney Blood Press Res; 2018 Sep 15; 43(2):329-349. PubMed ID: 29529602 [Abstract] [Full Text] [Related]
13. Late-onset endothelin receptor blockade in hypertensive heterozygous REN-2 transgenic rats. Vernerová Z, Kramer HJ, Bäcker A, Cervenka L, Opocenský M, Husková Z, Vanourková Z, Eis V, Chábová VC, Tesar V, Malý J, Vanecková I. Vascul Pharmacol; 2008 Sep 15; 48(4-6):165-73. PubMed ID: 18372220 [Abstract] [Full Text] [Related]
14. Endothelin receptor blockade does not affect blood pressure or angiotensin II levels in CYP1A1-Ren-2 transgenic rats with acutely induced hypertension. Vanourková Z, Kramer HJ, Erbanová M, Bäcker A, Cervenka L, Husková Z, Chábová VC, Tesar V, Dvorák P, Malý J, Vanecková I. Vascul Pharmacol; 2009 Sep 15; 50(5-6):194-9. PubMed ID: 19563737 [Abstract] [Full Text] [Related]
15. V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin-angiotensin system inhibition in rats with renal mass reduction. Perico N, Zoja C, Corna D, Rottoli D, Gaspari F, Haskell L, Remuzzi G. Kidney Int; 2009 Nov 15; 76(9):960-7. PubMed ID: 19625993 [Abstract] [Full Text] [Related]
19. Continuous inhibition of the renin-angiotensin system and protection from hypertensive end-organ damage by brief treatment with angiotensin II type 1 receptor blocker in stroke-prone spontaneously hypertensive rats. Takemori K, Ishida H, Ito H. Life Sci; 2005 Sep 16; 77(18):2233-45. PubMed ID: 15963533 [Abstract] [Full Text] [Related]
20. Protective effects of blocking renin-angiotensin system on the progression of renal injury in glomerulosclerosis. Ji Z, Huang C, Liang C, Chen B, Chen S, Sun W. Cell Mol Immunol; 2005 Apr 16; 2(2):150-4. PubMed ID: 16191423 [Abstract] [Full Text] [Related] Page: [Next] [New Search]